GENE ONLINE|News &
Opinion
Blog

2022-10-20| In-DepthSpecial

Leveraging Synthetic Biology, Microbiome-based Therapies Open Up Possibilities for Clinical Applications

by GeneOnline
Share To
Among all areas of development in synthetic biology, microbiome therapy is one of the most rapidly advancing and highly anticipated areas of technology. As the science community uncovers the close relationship between microbial ecology and human health, microbiomes are regarded as a “second genome” apart from the human genome, with extensive effects on gastrointestinal health, chronic diseases, cancer, and psychological disorders. As a result, clinical applications of microorganisms are becoming increasingly prevalent, ranging from therapeutics, diagnostics,  disease prevention, and novel carriers of therapeutic molecules. Companies and institutions are testing these in clinical trials, and regulatory agencies have approved some for marketing as derivative pharmaceutical products. With the main focus on microbiome therapy, this feature article will provide an in-depth overview of this promising technology's technical principles, clinical applications, and future trends.

GO Prime with only $1.49 now

LATEST
GeneOnline’s Weekly News Highlights: Sept 17-Sept 22
2023-09-26
Partnership to Manufacture Antibiotic to Combat Antimicrobial Resistance
2023-09-25
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Largest Biotech Event of Thailand Takes Center Stage
2023-09-22
BIOHK2023: A Place Where Biotechnology Meets Financial Economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top